These success, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two support the principle of focusing on ACKR3 as a singular strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Issues.Gene expression Investigation unveiled